Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samanthi A Perera

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Blood|June 7, 2003
Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML developmentJason A Wertheim, Samanthi A Perera, Daniel A Hammer, et al.
The American Journal of Pathology|July 5, 2008
Differential roles of telomere attrition in type I and II endometrial carcinogenesisEsra A Akbay, Cristina M Contreras, Samanthi A Perera, et al.
Carcinogenesis|February 20, 2008
Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancerSamanthi A Perera, Richard S Maser, Huili Xia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancerTakeshi Shimamura, Samanthi A Perera, Kevin P Foley, et al.
Nature Medicine|November 26, 2008
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersJeffrey A Engelman, Liang Chen, Xiaohong Tan, et al.
Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.
Cancer Research|July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistanceTakeshi Shimamura, Danan Li, Hongbin Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2009
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapySamanthi A Perera, Danan Li, Takeshi Shimamura, et al.
Cancer Cell|July 7, 2007
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapyDanan Li, Takeshi Shimamura, Hongbin Ji, et al.
Molecular Cancer Therapeutics|November 24, 2021
STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic TumorsSamanthi A Perera, Johnny E Kopinja, Yanhong Ma, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Blood|June 7, 2003
Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML developmentJason A Wertheim, Samanthi A Perera, Daniel A Hammer, et al.
The American Journal of Pathology|July 5, 2008
Differential roles of telomere attrition in type I and II endometrial carcinogenesisEsra A Akbay, Cristina M Contreras, Samanthi A Perera, et al.
Carcinogenesis|February 20, 2008
Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancerSamanthi A Perera, Richard S Maser, Huili Xia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancerTakeshi Shimamura, Samanthi A Perera, Kevin P Foley, et al.
Nature Medicine|November 26, 2008
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersJeffrey A Engelman, Liang Chen, Xiaohong Tan, et al.
Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.
Cancer Research|July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistanceTakeshi Shimamura, Danan Li, Hongbin Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2009
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapySamanthi A Perera, Danan Li, Takeshi Shimamura, et al.
Cancer Cell|July 7, 2007
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapyDanan Li, Takeshi Shimamura, Hongbin Ji, et al.
Molecular Cancer Therapeutics|November 24, 2021
STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic TumorsSamanthi A Perera, Johnny E Kopinja, Yanhong Ma, et al.
Pageof 2